{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:48:33Z","timestamp":1792018113590,"version":"4.4.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/mop.0b013e32834ea739","type":"journal-article","created":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T04:22:10Z","timestamp":1323490930000},"page":"1-8","source":"Crossref","is-referenced-by-count":96,"title":["New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome"],"prefix":"10.1097","volume":"24","author":[{"given":"David T.","family":"Teachey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210206","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.cdd.4401190","article-title":"Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.","volume":"10","author":"Rieux-Laucat","year":"2003","journal-title":"Cell Death Differ"},{"key":"R2-2-20210206","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor.","volume":"267","author":"Nagata","year":"1995","journal-title":"Science"},{"key":"R3-2-20210206","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1172\/JCI115867","article-title":"A novel lymphoproliferativeautoimmune syndrome resembling murine lprgld disease.","volume":"90","author":"Sneller","year":"1992","journal-title":"J Clin Invest"},{"key":"R4-2-20210206","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"R5-2-20210206","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"R6-2-20210206","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0889-8561(01)00011-X","article-title":"Autoimmune lymphoproliferative syndrome: a genetic disorder of abnormal lymphocyte apoptosis.","volume":"22","author":"Bleesing","year":"2002","journal-title":"Immunol Allergy Clin North Am"},{"key":"R7-2-20210206","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"R8-2-20210206","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2009.07991.x","article-title":"Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).","volume":"148","author":"Teachey","year":"2010","journal-title":"Br J Haematol"},{"key":"R9-2-20210206","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.4049\/jimmunol.1100021","article-title":"FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.","volume":"186","author":"Kuehn","year":"2011","journal-title":"J Immunol"},{"key":"R10-2-20210206","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/302333","article-title":"Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.","volume":"64","author":"Jackson","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R11-2-20210206","first-page":"2575","article-title":"Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.","volume":"94","author":"Rieux-Laucat","year":"1999","journal-title":"Blood"},{"key":"R12-2-20210206","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2002.03848.x","article-title":"Dominant expression of interleukin 10 but not interferon gamma in CD4(-)CD8(-)alphabetaT cells of autoimmune lymphoproliferative syndrome.","volume":"119","author":"Ohga","year":"2002","journal-title":"Br J Haematol"},{"key":"R13-2-20210206","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/blood-2008-09-179630","article-title":"FAS-L, IL-10, and double-negative CD4-CD8-TCR alphabeta T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.","volume":"113","author":"Magerus-Chatinet","year":"2009","journal-title":"Blood"},{"key":"R14-2-20210206","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMoa040036","article-title":"Autoimmune lymphoproliferative syndrome with somatic Fas mutations.","volume":"351","author":"Holzelova","year":"2004","journal-title":"N Engl J Med"},{"key":"R15-2-20210206","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/0003-4819-130-7-199904060-00020","article-title":"An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.","volume":"130","author":"Straus","year":"1999","journal-title":"Ann Intern Med"},{"key":"R16-2-20210206","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"R17-2-20210206","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI43752","article-title":"Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.","volume":"121","author":"Magerus-Chatinet","year":"2011","journal-title":"J Clin Invest"},{"key":"R18-2-20210206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00128072-200305030-00005","article-title":"Autoimmune lymphoproliferative syndrome: etiology, diagnosis, and management.","volume":"5","author":"Van der Werff ten Bosch","year":"2003","journal-title":"Paediatr Drugs"},{"key":"R19-2-20210206","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/1381612033392107","article-title":"Autoimmune lymphoproliferative syndrome (ALPS).","volume":"9","author":"Bleesing","year":"2003","journal-title":"Curr Pharm Des"},{"key":"R20-2-20210206","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0609.2007.00924.x","article-title":"Rituximab responsive immune thrombocytopenic purpura in an adult with underlying autoimmune lymphoproliferative syndrome due to a splice-site mutation (IVS72 TC) affecting the Fas gene.","volume":"79","author":"Wei","year":"2007","journal-title":"Eur J Haematol"},{"key":"R21-2-20210206","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00008480-199912000-00009","article-title":"Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.","volume":"11","author":"Jackson","year":"1999","journal-title":"Curr Opin Pediatr"},{"key":"R22-2-20210206","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood.V89.4.1341","article-title":"Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.","volume":"89","author":"Sneller","year":"1997","journal-title":"Blood"},{"key":"R23-2-20210206","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2141.2006.05993.x","article-title":"Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.","volume":"133","author":"Worth","year":"2006","journal-title":"Br J Haematol"},{"key":"R24-2-20210206","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/10428190310001593166","article-title":"Development of lymphoma in autoimmune lymphoproliferative syndrome (ALPS) and its relationship to Fas gene mutations.","volume":"45","author":"Poppema","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R25-2-20210206","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajh.20523","article-title":"Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).","volume":"81","author":"Rao","year":"2006","journal-title":"Am J Hematol"},{"key":"R26-2-20210206","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2004-09-3542","article-title":"Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).","volume":"105","author":"Teachey","year":"2005","journal-title":"Blood"},{"key":"R27-2-20210206","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00002281-200307000-00008","article-title":"Autoimmune lymphoproliferative syndrome.","volume":"15","author":"Sneller","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"R28-2-20210206","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2009.12.983","article-title":"Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.","volume":"125","author":"Caminha","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R29-2-20210206","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1182\/blood-2009-08-239525","article-title":"Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multiinstitutional study.","volume":"115","author":"Seif","year":"2010","journal-title":"Blood"},{"key":"R30-2-20210206","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature01063","article-title":"Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.","volume":"419","author":"Chun","year":"2002","journal-title":"Nature"},{"key":"R31-2-20210206","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.pas.0000157997.61177.08","article-title":"Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.","volume":"29","author":"Maric","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R32-2-20210206","first-page":"2976","article-title":"Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.","volume":"119","author":"Snow","year":"2009","journal-title":"J Clin Invest"},{"key":"R33-2-20210206","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1182\/blood-2010-07-295501","article-title":"Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis.","volume":"117","author":"Niemela","year":"2010","journal-title":"Blood"},{"key":"R34-2-20210206","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1073\/pnas.0702975104","article-title":"NRAS mutation causes a human autoimmune lymphoproliferative syndrome.","volume":"104","author":"Oliveira","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"R35-2-20210206","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood-2010-08-301515","article-title":"Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.","volume":"117","author":"Takagi","year":"2010","journal-title":"Blood"},{"key":"R36-2-20210206","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.clim.2007.08.010","article-title":"Increased lymphocyte Fas expression and high incidence of common variable immunodeficiency disorder in childhood Evans syndrome.","volume":"125","author":"Savasan","year":"2007","journal-title":"Clin Immunol"},{"key":"R37-2-20210206","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archinte.1951.03810010058005","article-title":"Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology.","volume":"87","author":"Evans","year":"1951","journal-title":"AMA Arch Intern Med"},{"key":"R38-2-20210206","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3324\/haematol.2010.036053","article-title":"New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children.","volume":"96","author":"Aladjidi","year":"2011","journal-title":"Haematologica"},{"key":"R39-2-20210206","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0031-3955(05)70272-8","article-title":"Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.","volume":"47","author":"Bleesing","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"R40-2-20210206","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/pbc.21965","article-title":"Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).","volume":"52","author":"Rao","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R41-2-20210206","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2141.2009.07715.x","article-title":"Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin.","volume":"146","author":"Cooper","year":"2009","journal-title":"Br J Haematol"},{"key":"R43-2-20210206","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"key":"R44-2-20210206","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2141.2005.05496.x","article-title":"Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.","volume":"129","author":"Rao","year":"2005","journal-title":"Br J Haematol"},{"key":"R45-2-20210206","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0041-1345(01)01965-0","article-title":"Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models.","volume":"33","author":"Izeradjene","year":"2001","journal-title":"Transplant Proc"},{"key":"R46-2-20210206","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/eji.201041078","article-title":"PI3KAKT inhibition elicits actin-independent and CD95-dependent apoptotic signalling through localisation of CD95 into lipid rafts.","volume":"41","author":"Pizon","year":"2011","journal-title":"Eur J Immunol"},{"key":"R47-2-20210206","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/TP.0b013e3181af20fd","article-title":"Increased interleukin-10 production without expansion of CD4CD25 T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.","volume":"88","author":"Mittal","year":"2009","journal-title":"Transplantation"},{"key":"R48-2-20210206","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor.","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R49-2-20210206","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1073\/pnas.90.2.770","article-title":"Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.","volume":"90","author":"Kulkarni","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"R50-2-20210206","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.molimm.2009.04.011","article-title":"Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-alpha expression in macrophages by reducing IL-10 expression.","volume":"46","author":"Baker","year":"2009","journal-title":"Mol Immunol"},{"key":"R52-2-20210206","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MPH.0b013e31802d7503","article-title":"Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome.","volume":"28","author":"Kossiva","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"R53-2-20210206","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood-2006-01-010124","article-title":"Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).","volume":"108","author":"Teachey","year":"2006","journal-title":"Blood"},{"key":"R54-2-20210206","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.07595.x","article-title":"Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.","volume":"145","author":"Teachey","year":"2009","journal-title":"Br J Haematol"},{"key":"R55-2-20210206","first-page":"233","article-title":"Autoimmune lymphoproliferative syndrome: new approaches to diagnosis and management.","volume":"9","author":"Teachey","year":"2011","journal-title":"Clin Adv Hematol Oncol"},{"key":"R56-2-20210206","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/pbc.22151","article-title":"Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.","volume":"53","author":"Janic","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R58-2-20210206","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.clpt.6100317","article-title":"Rapamycin: something old, something new, sometimes borrowed and now renewed.","volume":"82","author":"Hartford","year":"2007","journal-title":"Clin Pharmacol Ther"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e32834ea739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:27:37Z","timestamp":1786048057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-201202000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32834ea739","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}